Division 2.7 Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors

As regards Regulation (EC) No 273/2004, the Commission should be empowered to adopt implementing measures. Since those measures are of general scope and are designed to amend non-essential elements of Regulation (EC) No 273/2004, they must be adopted in accordance with the regulatory procedure with scrutiny provided for in Article 5a of Decision 1999/468/EC.

Accordingly, Regulation (EC) No 273/2004 is hereby amended as follows:

1. 1..

   Article 14 is hereby amended as follows:

   1. (a)

      the introductory sentence shall be replaced by the following:

      ‘Where necessary, the Commission shall adopt implementing measures concerning the following:’;

   2. (b)

      the following paragraphs shall be added:

      ‘The measures referred to in points (a) to (e) of the first paragraph, designed to amend non-essential elements of this Regulation, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 15(3).

      The measures referred to in point (f) of the first paragraph shall be adopted in accordance with the management procedure referred to in Article 15(2).’;

2. 2..

   Article 15 shall be replaced by the following:

   ‘Committee procedure

   Article 15

   1.

   The Commission shall be assisted by the Committee set up by Article 30 of Council Regulation (EC) No 111/2005^f2.

   2.

   Where reference is made to this paragraph, Articles 4 and 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.

   The period laid down in Article 4(3) of Decision 1999/468/EC shall be set at three months.

   3.

   Where reference is made to this paragraph, Article 5a(1) to (4) and Article 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.’